(b)(4).In addition to the difficulty in deploying, clinical assessment identified an unknown endoleak near the distal region of the bifurcated stent graft.The root cause of the reported difficulty deploying the bifurcated stent is unknown.The root cause of the endoleak of unknown origin was likely due to user-procedure related error.Clinical assessment identified that there was off label use of concomitant products, which is outside the ifu.Additionally, significant manipulations of the bifurcated stent graft delivery system following control cord break likely contributed to the event.Clinical was able to confirm the reported difficult deployment of the main body, collapsed proximal section of the main body, 2 non-endologix proximal extensions, and an unknown endoleak near distal bifurcated stent graft.Additionally, there was evidence to reasonably support the following observations: 2 non-endologix self-expanding stents placed in right iliac limb and right common iliac artery, and 1 non-endologix self-expanding stent placed in left iliac limb.A review of the device quality records shows that the device demonstrated compliance to established procedures and specifications at the time of manufacture.The devices were not returned, therefore no physical evaluation was completed.
|